Lazard Asset Management
TEVA icon

Lazard Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$24K Sell
1,484
-86,792
-98% -$1.4M ﹤0.01% 2108
2025
Q1
$1.36M Sell
88,276
-14,954
-14% -$230K ﹤0.01% 1097
2024
Q4
$2.28M Sell
103,230
-134,053
-56% -$2.95M ﹤0.01% 834
2024
Q3
$4.28M Sell
237,283
-302,477
-56% -$5.45M 0.01% 675
2024
Q2
$8.77M Buy
539,760
+470,582
+680% +$7.65M 0.01% 540
2024
Q1
$976K Sell
69,178
-36,561
-35% -$516K ﹤0.01% 931
2023
Q4
$1.1M Hold
105,739
﹤0.01% 933
2023
Q3
$1.08M Buy
+105,739
New +$1.08M ﹤0.01% 963
2018
Q4
Sell
-261
Closed -$5K 1087
2018
Q3
$5K Buy
+261
New +$5K ﹤0.01% 1013
2017
Q4
Sell
-21,336
Closed -$375K 1109
2017
Q3
$375K Sell
21,336
-2,002
-9% -$35.2K ﹤0.01% 735
2017
Q2
$775K Sell
23,338
-44,767
-66% -$1.49M ﹤0.01% 677
2017
Q1
$2.18M Sell
68,105
-10,138,619
-99% -$325M ﹤0.01% 646
2016
Q4
$370M Sell
10,206,724
-7,146,652
-41% -$259M 0.75% 43
2016
Q3
$798M Buy
17,353,376
+1,766,513
+11% +$81.3M 1.59% 13
2016
Q2
$783M Buy
15,586,863
+1,122,827
+8% +$56.4M 1.65% 13
2016
Q1
$774M Buy
14,464,036
+686,385
+5% +$36.7M 1.69% 13
2015
Q4
$904M Buy
13,777,651
+930,085
+7% +$61.1M 2.07% 7
2015
Q3
$725M Sell
12,847,566
-4,759,161
-27% -$269M 1.73% 13
2015
Q2
$1.04B Sell
17,606,727
-2,496,502
-12% -$148M 2.18% 3
2015
Q1
$1.25B Buy
20,103,229
+1,046,010
+5% +$65.2M 2.7% 1
2014
Q4
$1.1B Buy
19,057,219
+1,237,198
+7% +$71.2M 2.34% 1
2014
Q3
$958M Buy
17,820,021
+2,537,019
+17% +$136M 2.06% 4
2014
Q2
$801M Buy
15,283,002
+10,288,361
+206% +$539M 1.67% 8
2014
Q1
$264M Sell
4,994,641
-369,884
-7% -$19.5M 0.59% 50
2013
Q4
$215M Buy
5,364,525
+1,784,165
+50% +$71.5M 0.48% 65
2013
Q3
$135M Sell
3,580,360
-214,777
-6% -$8.11M 0.32% 83
2013
Q2
$149M Buy
+3,795,137
New +$149M 0.35% 74